Position in LENZ
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$193,381
+$37,621 QoQ
Shares Held
34,046
+100.0% QoQ
Ownership
0.108%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#62
of 143 holders
Holding Since
Sep 2024
8 quarters on record
Common Shares in LENZ Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026KELLEHER FINANCIAL ADVISORS holds $620,101 across 8 Biotechnology names. LENZ ranks #1 (31.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LENZ |
LENZ Therapeutics, Inc.
This page
|
34,046 | $193,381 | |
| 2 | MRNA |
Moderna, Inc.
|
2,670 | $186,980 | |
| 3 | 800,000 | $152,000 | |||
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
146 | $72,522 | |
| 5 | NKTR |
Nektar Therapeutics
|
150 | $10,471 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
9 | $2,168 | |
| 7 | PBYI |
Puma Biotechnology, Inc.
|
180 | $1,459 | |
| 8 | CRVS |
Corvus Pharmaceuticals, Inc.
|
75 | $1,120 |
All Filings in LENZ
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $193,381 | 34,046 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $155,760 | 17,023 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $272,368 | 17,023 | Shares | Sole | 2026-01-20 | |
| 2025-09-30 | $792,931 | 17,023 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $498,944 | 17,023 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $437,661 | 17,023 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $491,454 | 17,023 | Shares | Sole | 2025-01-17 | |
| 2024-09-30 | $493,151 | 20,773 | Shares | Sole | 2024-11-08 | |
| No filing history on record for this holder in this stock. | ||||||